Literature DB >> 19451135

High resolution array analysis: diagnosing pregnancies with abnormal ultrasound findings.

M Tyreman1, K M Abbott, L R Willatt, R Nash, C Lees, J Whittaker, I Simonic.   

Abstract

BACKGROUND: Genome-wide high resolution array analysis is becoming established as a diagnostic test in the investigation of individuals with learning disability and congenital anomalies; many novel microdeletion and microduplication syndromes have already been identified. The diagnostic use of high resolution array genomic hybridisation analysis for prenatal testing remains to be systematically assessed.
METHODS: We studied 106 prenatal samples with abnormal ultrasound and a normal karyotype using the Affymetrix GeneChip 6.0 array. "Rare" DNA copy number variations (CNVs) were classified into three groups depending on their size, genomic location and the presence or absence of matched copy number changes in a large cohort of 3000 control samples analysed for copy number changes using genotyping arrays.
RESULTS: A total of 35 rare CNVs were identified. 10 (9%) of these are considered likely to represent pathogenic CNVs; 5 were syndromic and 5 were novel. 12 CNVs were detected in at least one control hybridisation and likely to be benign, and 13 CNVs were of unknown clinical significance. In addition, we identified one case of cryptic mosaicism for trisomy 10, one case of loss of heterozygosity (LOH), and showed that the Affymetrix GeneChip 6.0 array platform can detect triploidy.
CONCLUSIONS: We conclude that careful implementation of high resolution array testing would benefit at least 10% of obstetric patients with abnormal ultrasound findings and a normal karyotype result.

Entities:  

Mesh:

Year:  2009        PMID: 19451135     DOI: 10.1136/jmg.2008.065482

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  25 in total

Review 1.  From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges.

Authors:  Diana W Bianchi
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

2.  Microarrays as a diagnostic tool in prenatal screening strategies: ethical reflection.

Authors:  Antina de Jong; Wybo J Dondorp; Merryn V E Macville; Christine E M de Die-Smulders; Jan M M van Lith; Guido M W R de Wert
Journal:  Hum Genet       Date:  2014-02       Impact factor: 4.132

3.  Application of SNP array for rapid prenatal diagnosis: implementation, genetic counselling and diagnostic flow.

Authors:  Malgorzata Srebniak; Marjan Boter; Grétel Oudesluijs; Marieke Joosten; Lutgarde Govaerts; Diane Van Opstal; Robert-Jan H Galjaard
Journal:  Eur J Hum Genet       Date:  2011-06-22       Impact factor: 4.246

4.  The causality of de novo copy number variants is overestimated.

Authors:  Joris R Vermeesch; Irina Balikova; Connie Schrander-Stumpel; Jean-Pierre Fryns; Koenraad Devriendt
Journal:  Eur J Hum Genet       Date:  2011-05-18       Impact factor: 4.246

Review 5.  Clinical geneticists' views of VACTERL/VATER association.

Authors:  Benjamin D Solomon; Kelly A Bear; Virginia Kimonis; Annelies de Klein; Daryl A Scott; Charles Shaw-Smith; Dick Tibboel; Heiko Reutter; Philip F Giampietro
Journal:  Am J Med Genet A       Date:  2012-11-19       Impact factor: 2.802

6.  Integration of microarray technology into prenatal diagnosis: counselling issues generated during the NICHD clinical trial.

Authors:  Ronald J Wapner; Deborah A Driscoll; Joe Leigh Simpson
Journal:  Prenat Diagn       Date:  2012-04       Impact factor: 3.050

7.  Chromosomal microarray versus karyotyping for prenatal diagnosis.

Authors:  Ronald J Wapner; Christa Lese Martin; Brynn Levy; Blake C Ballif; Christine M Eng; Julia M Zachary; Melissa Savage; Lawrence D Platt; Daniel Saltzman; William A Grobman; Susan Klugman; Thomas Scholl; Joe Leigh Simpson; Kimberly McCall; Vimla S Aggarwal; Brian Bunke; Odelia Nahum; Ankita Patel; Allen N Lamb; Elizabeth A Thom; Arthur L Beaudet; David H Ledbetter; Lisa G Shaffer; Laird Jackson
Journal:  N Engl J Med       Date:  2012-12-06       Impact factor: 91.245

Review 8.  Clinical impact of copy number variation analysis using high-resolution microarray technologies: advantages, limitations and concerns.

Authors:  Curtis R Coughlin; Gunter H Scharer; Tamim H Shaikh
Journal:  Genome Med       Date:  2012-10-30       Impact factor: 11.117

9.  An economic analysis of prenatal cytogenetic technologies for sonographically detected fetal anomalies.

Authors:  Lorie M Harper; Amelia L M Sutton; Ryan E Longman; Anthony O Odibo
Journal:  Am J Med Genet A       Date:  2014-03-24       Impact factor: 2.802

10.  Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound.

Authors:  Lisa G Shaffer; Jill A Rosenfeld; Mindy P Dabell; Justine Coppinger; Anne M Bandholz; Jay W Ellison; J Britt Ravnan; Beth S Torchia; Blake C Ballif; Allan J Fisher
Journal:  Prenat Diagn       Date:  2012-07-30       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.